I've had this on watch for a little while but the write-up in the AFR today is not encouraging.
They seem to be placing some reliance on their Skincare Clinics, within the Priceline pharmacies, to deliver a significant addition to profit. But as far as I can judge not all these pharmacies are big enough to provide this kind of service in the manner I assume most customers would expect.
I'm definitely not attracted just now, we'll see how it goes over this half year.
- Forums
- ASX - By Stock
- API
- News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln
News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln, page-3
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)